|Articles|February 25, 2021
Calyx Offers Scientific Consulting
Advertisement
Calyx has announced a scientific consulting program aimed at optimizing imaging processes and outcomes to accelerate the clinical development of new medical treatments.
Calyx Scientific Consulting delivers a range of services to meet the needs of new product development, including:
- Evaluating whether imaging is required based on specific endpoints
- Selecting imaging biomarkers to best demonstrate safety and efficacy at each trial phase
- Choosing the ideal image acquisition strategy to best support biomarker requirements
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
2
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
3
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
4
Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19
5